CEQUA 0.09% SOLUTION
FDA nonproprietary name: cyclosporine
For 1 unit (EA)
Pharmacies pay
$10.38 filed
1 × $10.38279 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$9.34 filed
1 × $9.33517 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
0.90× estimated
Medicare paid 10% less than pharmacies pay.
Part D averages every strength and form sold under “Cequa” / “Cyclosporine” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$16.94 estimated
$10.38 + $1.56 (15%) + $5.00 fee per fill = $16.94
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
CEQUA 0.09% SOLUTION is how the CMS NADAC file names this product. The FDA NDC Directory lists it as cyclosporine, under the trade name “CEQUA”.
FDA gives its dosage form as solution/ drops and its route as ophthalmic; topical.
The labeler, the company named on the label, is Sun Pharmaceutical Industries, Inc.
FDA’s Established Pharmacologic Class for it is Calcineurin Inhibitor Immunosuppressant.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 47335-0506-96.
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $10.38 for 1 unit (EA) (1 × $10.38279 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.
What NADAC measures · NADAC explanation codes
The NDC
- 47335-0506-96 · Sun Pharmaceutical Industries, Inc. · $10.38279 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
12 other products in the NADAC file share the FDA nonproprietary name cyclosporine with CEQUA 0.09% SOLUTION.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| CEQUA 0.09% SOLUTION this page | $10.38279 per EA filed | $9.33517 per EA filed |
| CYCLOSPORINE 0.05% EYE EMULSION | $0.90945 to $1.18033 per EA filed | $4.32927 per EA filed |
| CYCLOSPORINE 25 MG CAPSULE | $2.5957 per EA filed | $0.576 per EA derived |
| CYCLOSPORINE 100 MG CAPSULE | $7.50676 per EA filed | $1.455 per EA derived |
| CYCLOSPORINE MODIFIED 25 MG | $0.31377 per EA filed | $0.576 per EA derived |
| CYCLOSPORINE MODIFIED 50 MG | $0.76459 per EA filed | $0.7275 to $1.152 per EA derived |
| CYCLOSPORINE MODIFIED 100 MG | $1.23348 per EA filed | $1.455 per EA derived |
| CYCLOSPORINE MODIFIED 100 MG/ML | $2.03685 per ML filed | $1.455 per ML derived |
| GENGRAF 25 MG CAPSULE | $1.86549 per EA filed | $1.14257 per EA filed |
| NEORAL 25 MG GELATIN CAPSULE | $2.94566 per EA filed | $3.90784 per EA filed |
| NEORAL 100 MG GELATIN CAPSULE | $11.7731 per EA filed | $3.90784 per EA filed |
| RESTASIS 0.05% EYE EMULSION | $10.31247 to $10.31333 per EA filed | $10.19841 per EA filed |
| RESTASIS MULTIDOSE 0.05% EYE | $112.32159 per ML filed | $111.93625 per ML filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-02, 2026-07-08, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
Compared with its class
Its NADAC price is $10.38279 per EA filed.
Of the 19 other products in FDA’s Calcineurin Inhibitor Immunosuppressant class priced per EA, 1 has a higher middle NADAC price and 18 a lower one. The one in the middle is ASTAGRAF XL 0.5 MG CAPSULE, at $2.88173 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $9.34 for 1 unit (EA), at an average of $9.33517 per EA in 2024 (2024-01-01 to 2024-12-31) for “Cequa” and “Cyclosporine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 90,056 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 1 unit (EA)? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for CEQUA 0.09% SOLUTION labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Cequa / Cyclosporine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.
- Why does this page start at 1 unit (EA)?
- NADAC prices this product per EA, and the FDA NDC Directory lists its NDC as dosage form “SOLUTION/ DROPS” with route “OPHTHALMIC; TOPICAL”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and this is not one. NADAC’s EA for it may be a whole package (such as a kit, pen, syringe, vial or inhaler) or one dose inside it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.